The Supreme Court recently made a groundbreaking decision that is set to have a significant impact not only on Reglan lawsuits, but on a number of future side effects lawsuits. In June of 2011, the Supreme Court of the United States voted on a case called PLIVA v. Mensing, having to do with generic manufacturers of medications, namely the generic form of acid reflux drug Reglan, the generic of which is called metaclopramide. The Supreme Court voted that, as long as the labeling of the generic product exactly matched that of the name-brand drug, generic manufacturers could not be held liable in side effects lawsuits. Sunday, January 29, 2012
Reglan Supreme Court Decision Affects Lawsuits
The Supreme Court recently made a groundbreaking decision that is set to have a significant impact not only on Reglan lawsuits, but on a number of future side effects lawsuits. In June of 2011, the Supreme Court of the United States voted on a case called PLIVA v. Mensing, having to do with generic manufacturers of medications, namely the generic form of acid reflux drug Reglan, the generic of which is called metaclopramide. The Supreme Court voted that, as long as the labeling of the generic product exactly matched that of the name-brand drug, generic manufacturers could not be held liable in side effects lawsuits. 
Tuesday, January 10, 2012
Reglan Side Effects Cases Thrown Out, Could Be Re-Filed
A woman who filed a Reglan tardive dyskinesia case has had her case dismissed from court without prejudice, meaning the door remans open for further litigation in her case in the future. Virginia Carswell filed a lawsuit against five defendants, all companies that have something to do with the manufacture, marketing, or sale of Reglan and the generic equivalent, metoclopramide. The lawsuit, filed on the 27th of May in 2011, cited the fact that Reglan can lead to serious side effects for some patients.
Subscribe to:
Posts (Atom)